Avepoint Inc
$ 12.94
1.25%
03 Dec - close price
- Market Cap 2,792,314,000 USD
- Current Price $ 12.94
- High / Low $ 13.02 / 12.59
- Stock P/E N/A
- Book Value 2.20
- EPS -0.01
- Next Earning Report 2026-02-26
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.03 %
- ROE 0.01 %
- 52 Week High 20.25
- 52 Week Low 11.49
About
None
Analyst Target Price
$19.19
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-11-06 | 2025-08-07 | 2025-05-07 | 2025-02-26 | 2024-11-07 | 2024-08-08 | 2024-05-09 | 2024-02-29 | 2023-11-09 | 2023-08-09 | 2023-05-10 | 2023-03-09 |
| Reported EPS | 0.06 | 0.01 | 0.0467 | -0.0463 | 0.06 | -0.01 | 0.04 | 0.06 | 0.03 | -0.02 | -0.05 | -0.06 |
| Estimated EPS | 0.07 | 0.06 | 0.054 | 0.0522 | 0.05 | 0.02 | 0.01 | 0.04 | 0.02 | 0.01 | -0.01 | 0.02 |
| Surprise | -0.01 | -0.05 | -0.0073 | -0.0985 | 0.01 | -0.03 | 0.03 | 0.02 | 0.01 | -0.03 | -0.04 | -0.08 |
| Surprise Percentage | -14.2857% | -83.3333% | -13.5185% | -188.6973% | 20% | -150% | 300% | 50% | 50% | -300% | -400% | -400% |
Next Quarterly Earnings
| Dec 2025 | |
|---|---|
| Reported Date | 2026-02-26 |
| Fiscal Date Ending | 2025-12-31 |
| Estimated EPS | 0.0743 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: AVPT
2025-10-31 00:00:00
Jennison Associates LLC increased its stake in AvePoint, Inc. by 37.0% during Q2, purchasing 786,016 additional shares and bringing its total ownership to 2.9 million shares valued at $56.16 million. This comes amidst significant insider selling, with CEO Tianyi Jiang and a director selling over 2 million and 650,000 shares respectively. AvePoint currently holds a "Moderate Buy" consensus rating from analysts, with a price target range of $17.00 to $22.00.
2025-10-17 13:42:43
AvePoint has announced that it has ceased price stabilization actions related to a share offering, following significant share purchases. The over-allotment option was partially exercised to cover over-allotted shares, with the closing expected around October 24, 2025. UBS AG, Singapore Branch acted as the Stabilizing Manager for the offering.
2025-10-17 11:27:51
AvePoint has announced a secondary listing of its shares on the main board of the Singapore Exchange Securities Trading Limited (SGX-ST). UBS AG, Singapore Branch, acted as the Stabilizing Manager and purchased 9,240 shares of AvePoint’s common stock at S$18.10 to stabilize the offering. This strategic move aims to expand the company's market presence and boost investor confidence in the region.
2025-10-13 15:15:18
AvePoint has announced stabilization actions for its secondary listing on the Singapore Exchange Securities Trading Limited (SGX-ST). UBS AG, Singapore Branch, acting as the Stabilizing Manager, purchased 510 shares of AvePoint’s common stock in the open market at S$18.84 to support the offering and maintain share price stability. This move is part of the company’s efforts during its listing process.
2025-09-18 01:00:00
AvePoint has announced its dual listing on the Singapore Exchange (SGX), making it the first B2B SaaS stock on SGX and the first company dual-listed on Nasdaq and SGX. This move aims to expand AvePoint's global footprint, particularly in Asia, and follows a successful secondary offering that was more than three times oversubscribed. The company's Singapore presence already serves as its Asia Headquarters and International R&D Hub.
2025-08-12 09:20:00
AvePoint (AVPT) reported a swing to profit with US$2.7 million in net income and raised its full-year revenue guidance to US$406.6–410.6 million for 2025, signaling strong operational execution and demand. This improved outlook reduces concerns about competition and reinforces the company's investment narrative centered on growing enterprise needs for secure, compliant data management. The company anticipates significant revenue and earnings growth by 2028, with a fair value estimate suggesting a substantial upside.
